ISABS: Personalized Medicine Conference with Nobel Prize Laureates Participation to be held in Dubrovnik, Croatia

Food and Healthcare Press Releases Thursday March 16, 2017 08:37
ZAGREB, Croatia and WASHINGTON--16 Mar--PRNewswire/InfoQuest

International Society for Applied Biological Sciences (ISABS), Mayo Clinic and St. Catherine Hospital in partnership with Philips are organizing "The Tenth ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine" ( http://www.isabs.hr ), to be held in Dubrovnik, June 19th - June 24th, 2017. ISABS Conference is considered to be one of the most important scientific events in biomedicine in 2017. The conference topics includes: personalized and regenerative medicine, pharmacogenetics, molecular diagnostics, stem cell therapy, epigenetics, microbiome, cancer genetics, forensic and anthropological genetics, etc. There is no doubt: the future of medicine will rely on personalized treatments. During the ISABS 2017 Conference we would like to envision the power and advances of personalized medicine that will create significant value for the healthcare system.

(Logo: http://mma.prnewswire.com/media/465687/St_Catherine_Hospital_Logo.jpg )

More than 50 invited speakers from the World's best scientific institutions as well as 500 participants will attend the Conference. Five Nobel Lectures will be given by the Nobel Laureates: prof. Ada Yonath (Weizmann Institute of Science), prof. Robert Huber (Max Planck Institute of Biochemistry), prof. Avram Hershko (Technion), prof. Herald zur Hausen (University of Heidelberg) and prof. Paul Modrich (Duke University).

International Society for Applied Biological Sciences (ISABS) is a member of the Association Academy of the American Academy of Forensic Sciences and one of the most important and influential society in the field of forensic genetics and personalized medicine. ISABS Scientific Committee comprise four Nobel Prize laureates and many of the world's top physicians and scientists.

According to U.S. News & Word Report, Mayo Clinic is the #1 hospital overall, as well as #1 in more specialties than any other hospital in the United States.
St. Catherine Hospital is a European center of excellence, a finalist of the European Business Award and a member of the prestigious group "The Leading Hospitals of The World".

Royal Philips, a leading global company in health technology, is focused on improving people's health and enabling better outcomes with meaningful innovations. Philips is shaping the future of personalized medicine with tools and services that enable patient-specific care with first-time-right decision-making and targeted therapy.

More information on "The Tenth ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine" are available at http://www.isabs.hr .
ISABS 2017 Organizing Committee
info@isabs.hr
Contact: Severina Subotic +385-91-2445-589
Source: International Society for Applied Biological Sciences (ISABS)

Latest Press Release

ESMO Emphasises Importance of Cancer on Global Health Agenda at WHA

At the World Health Assembly in Geneva, ESMO delivered two statements positioning cancer as a priority on the WHO global agenda. (Photo: https://mma.prnewswire.com/media/696385/WHA_Global_Health_Agenda.jpg ) ESMO advocated the strengthening of health...

Real-World Evidence Shows Clinically Meaningful Weight Loss in People Receiving Saxenda(R)

People treated with Saxenda(R) (liraglutide 3 mg) for weight management lost an average of 8.1 kg after six months in a real-world clinical setting, in combination with diet and exercise. The data were presented this week at both the 25th European...

Venus Medtech#s strategic investment in Keystone Heart deepens the technical layout of cerebral embolic protection market

China Venus Medtech (Hangzhou) Inc. announced a partnership agreement for strategic investment and authorization with Keystone Heart. This agreement will grant Venus Medtech the right to exclusively develop, manufacture and sell the 3rd generation...

WCG (WIRB-Copernicus Group) Clinical Services Division Opens Office in Japan

WCG(TM) (WIRB-Copernicus Group(R)) Clinical Services Division, the world's leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced the opening of the company's new office in Tokyo, Japan....

Head-to-Head Trial Shows Refixia(R) Achieves Greater Total Factor IX Exposure in People With Haemophilia B Than Recombinant Factor IX-Fc Fusion Protein

Adults with haemophilia B who received a single dose Refixia(R) (nonacog beta pegol; N9-GP) achieved greater total factor IX exposure than those treated with rFIXFc (recombinant factor IX-Fc fusion protein). The head-to-head paradigm7 trial also observed...

Related Topics